These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 31629989

  • 1. Monitoring of infliximab trough levels and anti-infliximab antibodies in inflammatory bowel diseases: A comparison of three commercially available ELISA kits.
    Bertin D, Serrero M, Grimaud JC, Desjeux A, Desplat-Jégo S.
    Cytokine; 2020 Feb; 126():154859. PubMed ID: 31629989
    [Abstract] [Full Text] [Related]

  • 2. Comparison of three immunoassays for infliximab trough level monitoring in paediatric inflammatory bowel diseases.
    Villemonteix J, Guérin-El Khourouj V, Hugot JP, Giardini C, Carcelain G, Martinez-Vinson C.
    Biologicals; 2021 Apr; 70():17-21. PubMed ID: 33676831
    [Abstract] [Full Text] [Related]

  • 3. Comparison of three commercially available ELISA assays for anti-infliximab antibodies.
    West TA, Sam M, Toong C.
    Pathology; 2021 Jun; 53(4):508-514. PubMed ID: 33272693
    [Abstract] [Full Text] [Related]

  • 4. Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-α-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn's disease: systematic reviews and economic modelling.
    Freeman K, Connock M, Auguste P, Taylor-Phillips S, Mistry H, Shyangdan D, Court R, Arasaradnam R, Sutcliffe P, Clarke A.
    Health Technol Assess; 2016 Nov; 20(83):1-288. PubMed ID: 27845027
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
    Nasser Y, Labetoulle R, Harzallah I, Berger AE, Roblin X, Paul S.
    Dig Dis Sci; 2018 Oct; 63(10):2714-2721. PubMed ID: 29948562
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Determination of Serum Infliximab Concentration by Point-of-care Devices in Children With Inflammatory Bowel Disease.
    Curci D, Lucafò M, Cifù A, Bramuzzo M, Martelossi S, Favretto D, De Pellegrin F, Fabris M, Vascotto F, Naviglio S, Ventura A, Stocco G, Decorti G.
    J Pediatr Gastroenterol Nutr; 2019 Oct; 69(4):474-479. PubMed ID: 31149938
    [Abstract] [Full Text] [Related]

  • 8. Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.
    Marini JC, Sendecki J, Cornillie F, Popp JW, Black S, Blank M, Gils A, Van Stappen T, Hamann D, Rispens T, Thérien L, Chun K, Shankar G.
    AAPS J; 2017 Jan; 19(1):161-171. PubMed ID: 27600137
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic drug monitoring of infliximab: performance evaluation of three commercial ELISA kits.
    Schmitz EM, van de Kerkhof D, Hamann D, van Dongen JL, Kuijper PH, Brunsveld L, Scharnhorst V, Broeren MA.
    Clin Chem Lab Med; 2016 Jul 01; 54(7):1211-9. PubMed ID: 26587745
    [Abstract] [Full Text] [Related]

  • 11. Reliability evaluation of four different assays for therapeutic drug monitoring of infliximab levels.
    Pérez I, Fernández L, Sánchez-Ramón S, Alba C, Zatarain A, Cañas M, López ON, Olivares D, Rey E, Taxonera C.
    Therap Adv Gastroenterol; 2018 Jul 01; 11():1756284818783613. PubMed ID: 30034528
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 3 Enzyme-Linked Immunoassay Methods to Evaluate Serum Concentrations of Infliximab and Antibodies to Infliximab in 32 Patients with Moderate to Severe Inflammatory Bowel Disease.
    Jukic T, Drobne D, Pusavec S, Ihan A, Stubljar D, Starc A.
    Med Sci Monit; 2023 Feb 18; 29():e939084. PubMed ID: 36807319
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of two ELISA versions for infliximab serum levels in patients diagnosed with ankylosing spondylitis.
    Hernández-Flórez D, Valor L, de la Torre I, Nieto JC, Martínez-Estupiñán L, González C, López-Longo FJ, Monteagudo I, Garrido J, Naredo E, Carreño L.
    Rheumatol Int; 2015 Jun 18; 35(6):1021-5. PubMed ID: 25410014
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of infliximab drug measurement across three commercially available ELISA kits.
    Lee MW, Connor S, Ng W, Toong CM.
    Pathology; 2016 Oct 18; 48(6):608-12. PubMed ID: 27567230
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.